Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive B cells in autoimmune diseases
B cell targeting therapies are effective in various autoimmune diseases, among others rheumatoid art...
Work from multiple groups continues to provide additional evidence for the powerful and highly diver...
How autoreactive B cell responses initiate has been unclear. We have used the AM14 Rheumatoid Factor...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
B cells are essential for the development and pathogenesis of both systemic and organ-specific autoi...
B cells are essential for the development and pathogenesis of both systemic and organ-specific autoi...
B cell targeting therapies are effective in various autoimmune diseases, among others rheumatoid art...
A series of layered peripheral checkpoints maintain self-reactive B cells in an unresponsive state. ...
Autoreactive B cells are actively tolerized to more abundant self-antigens by a series of checkpoint...
Immune tolerance is critical to the avoidance of unwarranted immune responses against self antigens....
Immune tolerance is critical to the avoidance of unwarranted immune responses against self antigens....
B cell targeting therapies are effective in various autoimmune diseases, among others rheumatoid art...
Work from multiple groups continues to provide additional evidence for the powerful and highly diver...
How autoreactive B cell responses initiate has been unclear. We have used the AM14 Rheumatoid Factor...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the productio...
B cells are essential for the development and pathogenesis of both systemic and organ-specific autoi...
B cells are essential for the development and pathogenesis of both systemic and organ-specific autoi...
B cell targeting therapies are effective in various autoimmune diseases, among others rheumatoid art...
A series of layered peripheral checkpoints maintain self-reactive B cells in an unresponsive state. ...
Autoreactive B cells are actively tolerized to more abundant self-antigens by a series of checkpoint...
Immune tolerance is critical to the avoidance of unwarranted immune responses against self antigens....
Immune tolerance is critical to the avoidance of unwarranted immune responses against self antigens....
B cell targeting therapies are effective in various autoimmune diseases, among others rheumatoid art...
Work from multiple groups continues to provide additional evidence for the powerful and highly diver...
How autoreactive B cell responses initiate has been unclear. We have used the AM14 Rheumatoid Factor...